Effective Treatment of Retinal Neovascular Leakage with Fusogenic Porous Silicon Nanoparticles Delivering VEGF-siRNA
Nanomedicine · 2022
DOI: 10.2217/nnm-2022-0255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanomedicine, 2022. Verfasst von Joel F Grondek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Biochemistry, University of California, San Diego, CA 92093, USA. Hauptthemen laut MEDLINE: Retinal Neovascularization, Diabetic Retinopathy, Macular Edema, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIH HHS, University of California San Diego Chancellor’s Interdisciplinary Collaboratories Fellowship.
Abstract (Originalsprache)
Aim
To evaluate an intravitreally injected nanoparticle platform designed to deliver VEGF-A siRNA to inhibit retinal neovascular leakage as a new treatment for proliferative diabetic retinopathy and diabetic macular edema. Materials & methods: Fusogenic lipid-coated porous silicon nanoparticles loaded with VEGF-A siRNA, and pendant neovascular integrin-homing iRGD, were evaluated for efficacy by intravitreal injection in a rabbit model of retinal neovascularization.
Results
For 12 weeks post-treatment, a reduction in vascular leakage was observed for treated diseased eyes versus control eyes (p = 0.0137), with a corresponding reduction in vitreous VEGF-A.
Conclusion
Fusogenic lipid-coated porous silicon nanoparticles siRNA delivery provides persistent knockdown of VEGF-A and reduced leakage in a rabbit model of retinal neovascularization as a potential new intraocular therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry & Biochemistry, University of California, San Diego, CA 92093, USA.
- Department of Ophthalmology, Jacobs Retinal Center at Shiley Eye Institute, University of California, San Diego, CA 92093, USA.
- Materials Science & Engineering, University of California, San Diego, CA 92093, USA.
ORCID-Profile: Joel F Grondek
Förderung
- NEI NIH HHS
- NIH HHS
- University of California San Diego Chancellor’s Interdisciplinary Collaboratories Fellowship
- Joan and Irwin Jacobs Fellowship Fund, Shiley Eye Institue, Jacobs Retina Center, University of California San Diego
- Shiley Eye Institue, Jacobs Retina Center Grant, University of California San Diego
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Grondek, J. F., Huffman, K., Lee, E. J., Cavichini, M., Warter, A., P Kalaw, F. G., Heinke, A., Fan, R., Cheng, L., Sailor, M. J., & Freeman, W. R. (2022). Effective Treatment of Retinal Neovascular Leakage with Fusogenic Porous Silicon Nanoparticles Delivering VEGF-siRNA. Nanomedicine. https://doi.org/10.2217/nnm-2022-0255
Vancouver
Grondek JF, Huffman K, Lee EJ, Cavichini M, Warter A, P Kalaw FG, et al. Effective Treatment of Retinal Neovascular Leakage with Fusogenic Porous Silicon Nanoparticles Delivering VEGF-siRNA. Nanomedicine. 2022. doi:10.2217/nnm-2022-0255
BibTeX
@article{Grondek2022,
author = {Grondek, Joel F and Huffman, Kristyn and Lee, Ella Jiyoon and Cavichini, Melina and Warter, Alexandra and P Kalaw, Fritz Gerald and Heinke, Anna and Fan, Ruhan and Cheng, Lingyun and Sailor, Michael J and Freeman, William R},
title = {Effective Treatment of Retinal Neovascular Leakage with Fusogenic Porous Silicon Nanoparticles Delivering VEGF-siRNA},
journal = {Nanomedicine},
year = {2022},
doi = {10.2217/nnm-2022-0255}
}
EUVIMED